BioNTech SE (BNTX) Tax Provisions (2018 - 2025)
BioNTech SE (BNTX) posted Tax Provisions of -$90.3 million for Q4 2025, down 44.7% sequentially from -$62.4 million in Q3 2025, and down 102.71% YoY from $3.3 billion in Q4 2024.
BioNTech SE (BNTX) Tax Provisions (2018 - 2025) Analysis & Trends
BioNTech SE has reported Tax Provisions for 8 years, with the latest figure at -$90.3 million in Q4 2025.
- Quarterly Tax Provisions fell 102.71% year-over-year to -$90.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$103.4 million (down 803.48% YoY) and the FY2025 annual result came in at $96.4 million, up 827.31% from the prior year.
- Tax Provisions fell to -$90.3 million in Q4 2025 per BNTX's latest filing, from -$62.4 million in the prior quarter.
- Over five years, Tax Provisions peaked at $241.5 million in Q2 2023 and troughed at -$1.8 billion in Q4 2021.
- A 5-year average of -$485.3 million and a median of -$155.5 million in 2023 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2021 and 2025: Tax Provisions plunged 920631037.69% in 2021, then soared 946.17% in 2025.
- Over 5 years, Tax Provisions stood at -$1.8 billion in 2021, then jumped by 48.49% to -$912.0 million in 2022, then jumped by 75.78% to -$220.9 million in 2023, then surged by 79.83% to -$44.6 million in 2024, then sank by 102.71% to -$90.3 million in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered -$90.3 million, -$62.4 million, and $18.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | -90.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -90.33 Mn |
| Sep 30, 2025 | -62.43 Mn |
| Jun 30, 2025 | 18.22 Mn |
| Mar 31, 2025 | 31.14 Mn |
| Dec 31, 2024 | -44.56 Mn |
| Sep 30, 2024 | 43.27 Mn |
| Jun 30, 2024 | -2.15 Mn |
| Mar 31, 2024 | 18.14 Mn |
| Dec 31, 2023 | -220.89 Mn |
| Sep 30, 2023 | -72.72 Mn |
| Jun 30, 2023 | 241.52 Mn |
| Mar 31, 2023 | -220.57 Mn |
| Dec 31, 2022 | -912.00 Mn |
| Sep 30, 2022 | -664.65 Mn |
| Jun 30, 2022 | -690.71 Mn |
| Mar 31, 2022 | -1.48 Bn |
| Dec 31, 2021 | -1.77 Bn |
| Sep 30, 2021 | -1.72 Bn |
| Jun 30, 2021 | -1.49 Bn |
| Mar 31, 2021 | -620.25 Mn |